Articles
The Evolution of Antibody Drug Discovery: Unlocking Innovation with Bioinformatic and AIs
Since monoclonal antibodies (mAbs) were developed and received their first approval, they became indispensable as research tools and biotherapeutic agents.
The Innovation Imperative: Pioneering New Modalities for Therapeutic Leadership
In the rapidly evolving landscape of pharmaceuticals and biotechnology, the emergence of multimodal drug discovery heralds a transformative era for drug discovery, where innovation and strategic Foresight are paramount.
From early innovations to commercial triumphs: One viral vector partner for every stage of gene therapy development
Viral vector-based gene therapies hold promise for treating previously untreatable diseases like genetic disorders, rare cancers, and infectious diseases.
Outsourcing supply chain and buffer preparation activities
As the biopharmaceutical market evolves and continues a steep upward trajectory of growth, biopharmaceutical drug innovators increasingly rely on contract development and manufacturing organizations (CDMOs) to help them achieve their mission.
